Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | MIF | 92.0 | 53 | |
N2586 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 3 | MIF | 95.0 | 73 | |
RA2159 | IGF-I | 100 | ug/mL | 3 | MIF | 16.5 | 54 | ||||
RA2159 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 3 | MIF | 20.0 | 63 | |
RA2159 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | MIF | 19.0 | 50 | |
RA2159 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | MIF | 21.0 | 53 | |
RA2159 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | MIF | 19.5 | 44 | |
RA2159 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 3 | MIF | 23.0 | 62 | |
RA2159 | 3 | MIF | 23.0 | 65 | |||||||
N2586 | IGF-I | 100 | ug/mL | 3 | MIF | 70.0 | 61 | ||||
N2586 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 3 | MIF | 66.0 | 76 | |
N2586 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | MIF | 42.0 | 63 | |
N2586 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | MIF | 66.0 | 70 | |
N2586 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | MIF | 55.0 | 70 | |
N2586 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 3 | MIF | 43.0 | 59 | |
N2586 | 3 | MIF | 56.0 | 61 | |||||||
RA2159 | EGF | 100 | ng/mL | 3 | MIF | 21.0 | 66 | ||||
RA2159 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 3 | MIF | 19.0 | 57 | |
RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | MIF | 19.5 | 50 | |
RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | MIF | 21.0 | 46 | |
RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | MIF | 23.5 | 78 | |
RA2159 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 3 | MIF | 23.0 | 64 | |
RA2159 | JNK-IN-11 | 0.3 | uM | 3 | MIF | 20.0 | 63 | ||||
N2586 | EGF | 100 | ng/mL | 3 | MIF | 66.0 | 59 | ||||
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 3 | MIF | 75.0 | 71 |